Clinical Trials in Salt Lake City

Showing 8241-8260 of 12,670 trials

Phase I Newly Diagnosed GBM With Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/Temozolomide (D-TERMINED)

NCT02272270

This will be an open label, single arm study. Subjects with newly diagnosed high grade glioma will begin minocycline one week prior to beginning postoperative chemoradiation and continue it until progression, intolerance, or the end of adjuvant temozolomide, whichever comes first.

Newly Diagnosed High Grade Glioma

University of Utah25 participantsStarted Oct 2014

Salt Lake City, Utah, United States

COMPLETEDPhase 3< 1 mile

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

NCT01190189

This extension study is designed to assess the safety of GSK Biological's human papillomavirus (HPV) vaccine GSK580299 in female subjects who took part in the primary study NCT00294047 and received the control vaccine in countries for which the licensed GSK HPV vaccine is not indicated for the subject's age group (26 years and older). This study is thus conducted to enable all women who received the control placebo in the primary NCT00294047 study to receive the GSK580299 vaccine.

Infections, Papillomavirus

GlaxoSmithKline137 participantsStarted Apr 2011

Aurora, Colorado, United States • Golden, Colorado, United States • Coral Gables, Florida, United States +25 more locations

Phase I Newly Diagnosed GBM With Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/Temozolomide (D-TERMINED)

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Find Trials by Condition in Salt Lake City

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)

A Novel Treatment for Aphasia and Apraxia of Speech : Measurement of Outcomes

Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

National Prevalence and Impact of Noninvasive Prenatal Testing

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age

Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

Assessing Superion Clinical Endpoints vs. Decompression